A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...

There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among ...

Herpes zoster vaccination is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older.

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of ...

Pritelivir demonstrated numerically improved efficacy relative to foscarnet, and a more favourable safety and tolerability ...

The results also highlight the fact that one shot may still be better than none. Having at least one dose prevented an estimated 698 cases of herpes zoster, 58 cases of ocular involvement, and 78 ...

A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...

Shingles vaccine recipients who had a breakthrough infection experienced no reduction in all-cause dementia compared with those who received a pneumonia vaccine. They trended toward fewer post-zoster ...

Today, Assembly Biosciences, Inc. (NASDAQ:ASMB) released results from its phase 1b study using its long-acting herpes simplex virus [HSV] helicase-primase inhibitor ABI-5366 for the treatment of ...

HealthDay News — Vaccination against herpes zoster (HZ) is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older, according to a study presented ...